Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001437749-19-011280
Filing Date
2019-06-03
Accepted
2019-06-03 16:43:54
Documents
1
Effectiveness Date
2019-06-03
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11387
  Complete submission text file 0001437749-19-011280.txt   12827
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-341007 | Film No.: 19873838
SIC: 2834 Pharmaceutical Preparations